Related Experiment Video

Updated: Aug 24, 2026

Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
03:10

Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst

Published on: March 31, 2023

[Cardio-pericardial hydatid cyst. Report of 19 cases]

Sofiane Jerbi1, Chokri Kortas, Sami Dammak

  • 1Département de chirurgie cardio-vasculaire et thoracique, Hôpital Sahloul Sousse.

La Tunisie Medicale
|May 7, 2004
PubMed

Insights

Surgical treatment for cardio-pericardial hydatid cysts is effective, with transesophageal echocardiography (TEE) aiding diagnosis. Surgery using cardiopulmonary bypass (CPB) shows good outcomes, with no observed relapses in patients.

Area of Science:

  • Cardiology
  • Parasitology
  • Thoracic Surgery

Context:

  • Hydatid cysts can affect the heart and pericardium, posing significant surgical challenges.
  • Diagnosis and surgical management of cardio-pericardial hydatid cysts require specialized approaches.

Purpose:

  • To evaluate the surgical outcomes for cardio-pericardial hydatid cysts.
  • To highlight the role of transesophageal echocardiography (TEE) in diagnosis and cardiopulmonary bypass (CPB) in surgical treatment.

Summary:

  • Nineteen patients underwent surgery for cardio-pericardial hydatid cysts between 1991 and 2003.
  • Transesophageal echocardiography (TEE) was the preferred diagnostic tool.
  • Surgery with cardiopulmonary bypass (CPB) was performed 15 times, with left ventricular cysts being most frequent. A single immediate postoperative death occurred, with 2 late deaths among 17 followed patients. No relapses were observed.

Impact:

  • Surgical intervention with CPB offers a viable treatment option for cardio-pericardial hydatid cysts.
  • The study demonstrates a low recurrence rate, suggesting the effectiveness of the surgical technique.
  • Early and late mortality, though present, did not negate the overall positive surgical outcomes.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...